75 related articles for article (PubMed ID: 2636208)
1. Blood bioamines, cortisol and aminoacid levels in leukemic patients.
Singh JN; Chansouria JP; Singh VP; Udupa KN
Indian J Cancer; 1989 Dec; 26(4):222-6. PubMed ID: 2636208
[TBL] [Abstract][Full Text] [Related]
2. [The thrombocytic beta-thromboglobulin level of patients with blastic leukemia and chronic myeloleukemia].
Genova V; Kurtev I
Vutr Boles; 1988; 27(4):54-7. PubMed ID: 2975086
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.
Chai SK; Nichols GL; Rothman P
J Immunol; 1997 Nov; 159(10):4720-8. PubMed ID: 9366395
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
5. [Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR].
Qin YZ; Ruan GR; Liu YR; Li JL; Fu JY; Wang H; Chang Y; Jiang B; Jiang Q; Jiang H; Qiu JY; Chen SS; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):1-5. PubMed ID: 15946498
[TBL] [Abstract][Full Text] [Related]
6. Platelet function in acute leukemias.
Naresh KN; Sivasankaran P; Veliath AJ
J Assoc Physicians India; 1993 Jun; 41(6):377-8. PubMed ID: 8005978
[TBL] [Abstract][Full Text] [Related]
7. Non-Newtonian rheology of leukemic blood and plasma: are n and k parameters of power law model diagnostic?
Sharma K; Bhat SV
Physiol Chem Phys Med NMR; 1992; 24(4):307-12. PubMed ID: 1296211
[TBL] [Abstract][Full Text] [Related]
8. [Free amino acids in leukemic leukocytes].
Maj S; Sitarska E; Szczygiel M
Acta Haematol Pol; 1977; 8(1):15-20. PubMed ID: 265661
[TBL] [Abstract][Full Text] [Related]
9. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia.
Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
Exp Hematol; 1995 Aug; 23(9):1030-4. PubMed ID: 7543415
[TBL] [Abstract][Full Text] [Related]
10. Cellular deformability studies in leukemia.
Sharma K
Physiol Chem Phys Med NMR; 1993; 25(4):293-7. PubMed ID: 8153154
[TBL] [Abstract][Full Text] [Related]
11. Thyroid function in severe "nonthyroidal illness". Longitudinal studies in haematological patients.
Földes J; Váradi G; Lakatos P; Bános C; Tarján G
Acta Med Hung; 1989; 46(2-3):133-42. PubMed ID: 2812957
[TBL] [Abstract][Full Text] [Related]
12. Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects.
Butt NM; Rojas JM; Wang L; Christmas SE; Abu-Eisha HM; Clark RE
Haematologica; 2005 Oct; 90(10):1315-23. PubMed ID: 16219567
[TBL] [Abstract][Full Text] [Related]
13. Leukemic colony formation from patients with acute leukemia: evidence of the identity in karyotype of the colonies from patients with cytogenetic abnormalities.
Ishibashi T
Fukushima J Med Sci; 1987 Dec; 33(2):71-83. PubMed ID: 3509037
[No Abstract] [Full Text] [Related]
14. [Changes in the level of various amino acids in leukemia].
Loeper J; Debray J; Cottet J; Loeper J
Nouv Presse Med; 1977 Feb; 6(7):539-43. PubMed ID: 265067
[TBL] [Abstract][Full Text] [Related]
15. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547
[TBL] [Abstract][Full Text] [Related]
16. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
Prejzner W
Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
[TBL] [Abstract][Full Text] [Related]
17. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
[TBL] [Abstract][Full Text] [Related]
18. [Detection and quantification of BCR-ABL transcripts in patients with chronic myeloid leukemia by real-time quantitative reverse transcriptase polymerase chain reaction].
Xing W; Gu BW; Zhu YM; Jiang CL; Zhao RH; Wang AH; Sun HP; Li JM; Shen ZX; Chen Z; Chen SJ
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):453-7. PubMed ID: 15854550
[TBL] [Abstract][Full Text] [Related]
19. Intracellular cytokine analysis of interferon-gamma in T cells of patients with chronic myeloid leukemia.
Aswald JM; Lipton JH; Messner HA
Cytokines Cell Mol Ther; 2002 Dec; 7(2):75-82. PubMed ID: 12607798
[TBL] [Abstract][Full Text] [Related]
20. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
